Linked diimidazole derivatives
    42.
    发明授权
    Linked diimidazole derivatives 有权
    连接的二咪唑衍生物

    公开(公告)号:US08637561B2

    公开(公告)日:2014-01-28

    申请号:US12707200

    申请日:2010-02-17

    摘要: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

    摘要翻译: 本发明公开了式(I)化合物或其药学上可接受的盐,酯或前药:其抑制含RNA病毒,特别是丙型肝炎病毒(HCV)。 因此,本发明的化合物干扰丙型肝炎病毒的生命周期,也可用作抗病毒剂。 本发明还涉及药物组合物,其包含用于给患有HCV感染的受试者施用的上述化合物。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的HCV感染的方法。

    Nanofibers and methods of making same and using same in humidity sensors
    44.
    发明授权
    Nanofibers and methods of making same and using same in humidity sensors 失效
    纳米纤维及其制作方法,并在湿度传感器中使用相同的方法

    公开(公告)号:US08225641B2

    公开(公告)日:2012-07-24

    申请号:US12544989

    申请日:2009-08-20

    IPC分类号: G01N19/10

    摘要: A self-cleaning humidity sensor based on Mg2+/Na+-doped TiO2 nanofiber mats is provided. Examples show the response and recovery characteristic curves for ten circles with the RH changing from 11% to 95%. The nanofibers are manufactured by mixing together a metal salt comprising titanium, a magnesium compound, a sodium compound, and a high molecular weight material to form a mixture, electrospinning the mixture to form composite nanofibers, and calcining the composite nanofibers to yield a TiO2 nanofiber material doped with magnesium and sodium.

    摘要翻译: 提供了基于Mg2 + / Na +掺杂的TiO2纳米纤维垫的自洁湿度传感器。 示例显示了10个圆的响应和恢复特性曲线,RH从11%变化到95%。 纳米纤维通过将包含钛,镁化合物,钠化合物和高分子量材料的金属盐混合在一起而制备,以形成混合物,静电纺混合物以形成复合纳米纤维,并煅烧复合纳米纤维以产生TiO 2纳米纤维 掺杂镁和钠的材料。

    TECHNIQUES TO PERFORM FAST MOTION ESTIMATION
    48.
    发明申请
    TECHNIQUES TO PERFORM FAST MOTION ESTIMATION 有权
    执行快速运动估计的技术

    公开(公告)号:US20100080297A1

    公开(公告)日:2010-04-01

    申请号:US12241662

    申请日:2008-09-30

    申请人: Ce Wang Walid Ali

    发明人: Ce Wang Walid Ali

    IPC分类号: H04N7/26

    摘要: Techniques to perform fast motion estimation are described. An apparatus may comprise a motion estimator operative to receive as input a current frame and a reference frame from a digital video sequence. The motion estimator may generate and output a motion vector. The motion vector may represent a change in position between a current block of the current frame and a matching reference block of the reference frame. The motion estimator may utilize an enhanced block matching technique to perform block matching based on stationary and spatially proximate blocks. Other embodiments are described and claimed.

    摘要翻译: 描述了执行快速运动估计的技术。 一种装置可以包括运动估计器,用于从数字视频序列接收当前帧和参考帧作为输入。 运动估计器可以生成和输出运动矢量。 运动矢量可以表示当前帧的当前块和参考帧的匹配参考块之间的位置变化。 运动估计器可以利用增强的块匹配技术来执行基于固定和空间上邻近块的块匹配。 描述和要求保护其他实施例。

    SUBSTITUTE PYRROLIDINE DERIVATIVES
    49.
    发明申请
    SUBSTITUTE PYRROLIDINE DERIVATIVES 审中-公开
    替代吡咯烷衍生物

    公开(公告)号:US20090053175A1

    公开(公告)日:2009-02-26

    申请号:US12196642

    申请日:2008-08-22

    摘要: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention relates to novel antiviral compounds represented herein above, pharmaceutical compositions comprising such compounds, and methods for the treatment or prophylaxis of viral (particularly HCV) infection in a subject in need of such therapy with said compounds.

    摘要翻译: 本发明公开了式(I)化合物或其药学上可接受的盐,酯或前药:其抑制含RNA病毒,特别是丙型肝炎病毒(HCV)。 因此,本发明的化合物干扰丙型肝炎病毒的生命周期,也可用作抗病毒剂。 本发明还涉及药物组合物,其包含用于给患有HCV感染的受试者施用的上述化合物。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的HCV感染的方法。 本发明涉及上文所示的新的抗病毒化合物,包含这些化合物的药物组合物,以及用于治疗或预防需要用所述化合物治疗的受试者中的病毒(特别是HCV)感染的方法。

    Controlling loop filtering for interlaced video frames
    50.
    发明申请
    Controlling loop filtering for interlaced video frames 审中-公开
    控制隔行视频帧的环路滤波

    公开(公告)号:US20080084932A1

    公开(公告)日:2008-04-10

    申请号:US11544382

    申请日:2006-10-06

    IPC分类号: H04N11/04 H04B1/66

    摘要: Techniques and tools are described for parameterization, signaling and use of in-loop filtering control information for interlaced video frames in video acceleration. For example, for a macroblock of an interlaced video frame, a decoder parameterizes in-loop filtering decisions as filter control information for video acceleration. The control information indicates filtering control decisions for external edges and internal edges of luma blocks and chroma blocks of the macroblock. The decoder makes the control information available to a video accelerator. The video accelerator retrieves the in-loop filtering control information. For a macroblock of an interlaced video frame, the video accelerator then performs in-loop filtering based at least in part on the control information.

    摘要翻译: 描述技术和工具用于视频加速中的隔行视频帧的参数化,信令和使用环路滤波控制信息。 例如,对于隔行视频帧的宏块,解码器将环路滤波决定参数化为用于视频加速的滤波器控制信息。 控制信息表示对于宏块的亮度块和色度块的外部边缘和内部边缘的滤波控制决定。 解码器使控制信息可用于视频加速器。 视频加速器检索循环过滤控制信息。 对于隔行视频帧的宏块,视频加速器至少部分地基于控制信息来执行循环过滤。